In a 2026 ruling , the court allowed most of the amended claims to proceed, while dismissing a narrower civil conspiracy claim for lack of sufficient supporting detail
Breaking: Regeneron may have just improved upon basic GLP-1 weight loss therapy - - - New Phase 2 COURAGE trial top-line data suggest that combining semaglutide (Wegovy/Ozempic) with muscle-preserving antibodies could dramatically improve the quality of weight lossnot just the quantity
Important: Compounded medications are not FDA-evaluated for safety or efficacy
Investigators reported a 38% higher risk of kidney cancer in GLP-1 users compared to non-users, noting that while the result was marginally nonsignificant, it remains concerning due to the widespread use of these drugs
Injectable formulations may offer more consistent blood sugar control due to their superior bioavailability and steady drug levels throughout the week
Embrace the journey, stay consistent, and celebrate every milestone along the way
